ATE309807T1 - Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält - Google Patents
Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthältInfo
- Publication number
- ATE309807T1 ATE309807T1 AT00963821T AT00963821T ATE309807T1 AT E309807 T1 ATE309807 T1 AT E309807T1 AT 00963821 T AT00963821 T AT 00963821T AT 00963821 T AT00963821 T AT 00963821T AT E309807 T1 ATE309807 T1 AT E309807T1
- Authority
- AT
- Austria
- Prior art keywords
- statin
- patient
- treatment
- composition
- treated blood
- Prior art date
Links
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 title abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000011284 combination treatment Methods 0.000 abstract 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 abstract 1
- 239000003529 anticholesteremic agent Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 230000008646 thermal stress Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Aggression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002283374A CA2283374A1 (en) | 1999-09-24 | 1999-09-24 | Combination therapies for treating atherosclerosis in mammals |
| CA002283975A CA2283975A1 (en) | 1999-09-28 | 1999-09-28 | Combined therapies for atherosclerosis treatment |
| PCT/CA2000/001112 WO2001022976A2 (en) | 1999-09-24 | 2000-09-25 | Combination of a statin and ex-vivo treated blood for treating artheroclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE309807T1 true ATE309807T1 (de) | 2005-12-15 |
Family
ID=25681214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00963821T ATE309807T1 (de) | 1999-09-24 | 2000-09-25 | Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7125897B1 (de) |
| EP (1) | EP1218017B1 (de) |
| JP (1) | JP2003510284A (de) |
| AT (1) | ATE309807T1 (de) |
| AU (1) | AU7500200A (de) |
| DE (1) | DE60024114T2 (de) |
| WO (1) | WO2001022976A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090204051A1 (en) * | 2005-03-30 | 2009-08-13 | Kaneka Corporation | Method of removing lymphocyte growth inhibitor |
| US20070116755A1 (en) * | 2005-11-22 | 2007-05-24 | Zadini Filiberto P | Dissolution of arterial cholesterol plaques by pharmacological preparation |
| CA2642741A1 (en) * | 2006-01-24 | 2007-08-02 | Nomir Medical Technologies, Inc. | Optical method and device for modulation of biochemical processes in adipose tissue |
| US8541645B2 (en) * | 2009-10-22 | 2013-09-24 | University Of Calcutta | Animal model for cigarette-smoke-induced atherosclerosis and related methods |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284869A (en) * | 1991-12-17 | 1994-02-08 | Emil Bisaccia | Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty |
| US5980954A (en) * | 1992-02-07 | 1999-11-09 | Vasogen Ireland Limited | Treatment of autoimmune diseases |
| GB9617611D0 (en) * | 1996-08-22 | 1996-10-02 | Vasogen Inc | Treatment of autoimmune disease |
| PL172480B1 (pl) * | 1992-11-20 | 1997-09-30 | Univ British Columbia | Kompozycja do niszczenia lub uszkadzania obszaru nowego unaczynienia PL PL |
| CA2194485C (en) | 1995-05-05 | 2001-09-18 | Anthony Ernest Bolton | Endothelial lining effects and treatment of vasospastic disorders |
| GT199800126A (es) | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
| PT1011696E (pt) | 1997-09-12 | 2004-03-31 | Vasogen Ireland Ltd | Tratamento do stresse e precondicoes contra o stresse |
| US6432399B1 (en) * | 1997-09-12 | 2002-08-13 | Vasogen Ireland Limited | Treatment of stress and preconditioning against stress |
| CA2348599A1 (en) | 1998-11-13 | 2000-05-25 | Vasogen Ireland Limited | Method for preventing and reversing atherosclerosis in mammals |
| US6264646B1 (en) * | 1998-11-13 | 2001-07-24 | Vasogen Ireland Limited | Method for preventing and reversing atherosclerosis in mammals |
-
2000
- 2000-09-25 US US10/089,362 patent/US7125897B1/en not_active Expired - Fee Related
- 2000-09-25 JP JP2001526186A patent/JP2003510284A/ja active Pending
- 2000-09-25 EP EP00963821A patent/EP1218017B1/de not_active Expired - Lifetime
- 2000-09-25 AU AU75002/00A patent/AU7500200A/en not_active Abandoned
- 2000-09-25 AT AT00963821T patent/ATE309807T1/de not_active IP Right Cessation
- 2000-09-25 WO PCT/CA2000/001112 patent/WO2001022976A2/en not_active Ceased
- 2000-09-25 DE DE60024114T patent/DE60024114T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60024114T2 (de) | 2006-08-03 |
| EP1218017A2 (de) | 2002-07-03 |
| WO2001022976A3 (en) | 2001-10-25 |
| AU7500200A (en) | 2001-04-30 |
| US7125897B1 (en) | 2006-10-24 |
| EP1218017B1 (de) | 2005-11-16 |
| JP2003510284A (ja) | 2003-03-18 |
| DE60024114D1 (de) | 2005-12-22 |
| WO2001022976A2 (en) | 2001-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60030124D1 (de) | Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben | |
| DE60028863D1 (de) | Elektrochirurgisches Handstück zur Behandlung von Gewebe | |
| DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
| DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
| DE60022916D1 (de) | Reboxetin zur Behandlung von peripheren Neuropathien | |
| CY1115117T1 (el) | Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα | |
| ATE476155T1 (de) | In-vitro herstellung von transplantierbarem knorpelgewebe | |
| TR199901172T2 (xx) | Yeni ikame edilmi� pirazol t�revleri. | |
| DE69526120D1 (de) | Verwendung von nebivolol als anti-atherogenisches mittel | |
| ATE350030T1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| ATE238792T1 (de) | Verwendung von makroliden zur behandlung von glaukom | |
| ATE97316T1 (de) | Kosmetisches mittel und zusammensetzung zur behandlung der haut. | |
| ATE269077T1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
| NO166939C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater. | |
| DE60018569D1 (de) | Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| FR2713640B1 (fr) | Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. | |
| ATE296635T1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
| ES2163805T3 (es) | Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars. | |
| ATE309807T1 (de) | Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält | |
| DE60018200D1 (de) | Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen | |
| ATE246929T1 (de) | Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen | |
| DE69916488D1 (de) | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren | |
| DE69621786D1 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
| ATE195072T1 (de) | Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |